miércoles, 21 de octubre de 2009

SANDOZ "pone el ojo" en Japón...

The additions will bring to 13 the number of drugs Sandoz is introducing in Japan this year, Chief Executive Officer Jeff George said at a group interview in Tokyo yesterday, without identifying the treatments. The company plans to sell at least 10 new drugs a year in Japan until 2014, he said.

.../...

Sandoz seeks to bolster growth in what George calls emerging generic markets, including France, Italy and Japan, where lower use of copied drugs leaves room for growth. Generics made up 18 percent of drug sales volume in Japan in the year to March 31, while IMS Health Inc. estimates that such medicines account for about 63 percent of drugs prescribed in the U.S. (Ver...)

No hay comentarios: